GlassScriptPhysician profile
Amanda Purnell
NPI 1063178119
$147.96
in general payments reported to CMS, 2019-2025
9 companies · $25.70 in 2025
The $25.70 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $122 · 2025: $25.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $122 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.26 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $25.70 | 2025 | Lynparza |
| Gilead Sciences, INC. | $19.11 | 2023 | Trodelvy |
| Lilly USA, LLC | $16.45 | 2023 | Verzenio, Jaypirca |
| Seagen INC. | $16.40 | 2023 | Tukysa |
| Immunogen, INC. | $14.81 | 2023 | Elahere |
| Array Biopharma INC | $14.18 | 2023 | Braftovi, Mektovi, Lorbrena |
| Amgen INC. | $13.88 | 2023 | Blincyto, Kyprolis |
| Genentech USA, INC. | $13.82 | 2023 | Perjeta |
| Daiichi Sankyo INC. | $13.61 | 2023 | Enhertu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Purnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.